Real-time enrollment status for this metastatic melanoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:09 AM UTC
| NCT Number | NCT03646617 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Melanoma |
| Phase | Clinical Trial |
| Target Enrollment | 54 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | August 13, 2025 (Aug 13, 2025) |
As of March 2, 2026: Clinical trial NCT03646617 is currently recruiting participants. This clinical trial study for metastatic melanoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03646617 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03646617 was last updated Aug 13, 2025 (August 13, 2025). HelloStudys verifies this status automatically.